Formulary Monographs [FLUTICASONE|VILANTEROL, 4892]
|
|
FLUTICASONE | VILANTEROL
|
|
|
|
|
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
Long-term maintenance of airflow obstruction in p atients with chronic obstructive pulmonary disease (COPD).
|
|
|
Close monitoring for glaucoma and cataracts is warranted. Do not
use in combination with an additional LABA because of risk of overdose. Naso-pharyngitis, upper respiratory tract infection, head ache, and oral candidiasis. After inhalation, the patient should rinse his/her mouth with water without swallowing to help reduce the risk of oropharyngeal candidiasis. |
|
|
One inhalation once daily at the same time each day .
|
|
|
|
|
|
|
|
|
|
|
|
|